Navigation Links
MSU researchers receive $400,000 in first wave of stimulus funding
Date:6/4/2009

EAST LANSING, Mich. A pair of Michigan State University professors have received a total of nearly $400,000 for their cardiovascular research projects as part of the first wave of stimulus funding from federal agencies.

The money, from the National Institutes of Health via the American Recovery and Reinvestment Act, will help to preserve and create jobs in Michigan while also investing in important medical research, said U.S. Sen. Carl Levin, whose office announced the awards.

Narayanan Parameswaran, an assistant professor in MSU's Department of Physiology, received $375,141 for his research on the molecular aspects in the development of chronic diseases. His work in particular focuses on atherosclerosis, one of the major causes of heart attack and stroke.

"Understanding how atherosclerosis develops is an important question in cardiovascular medicine, because if we understand the 'how', then we can eventually use that information to develop therapeutic drugs to prevent or treat this disease," he said.

Parameswaran's study focuses on how a certain protein called "GRK2" affects the development of atherosclerosis. The research will help determine if the protein can be targeted for drug development in the treatment of atherosclerosis and other chronic diseases.

Gregory Fink, a professor in the Department of Pharmacology and Toxicology, received $17,632 for a research project he's doing on hypertension. Fink will use the money to have a student work in the laboratory of MSU colleague James Galligan on a project looking at the causes of high blood pressure.

"The work specifically looks at how a high-salt diet affects the arteries and veins in the gastrointestinal system," Fink said of the project, which is in its seventh year at MSU.

The money announced June 2 was part of $2.7 million in NIH funding that went to six institutions statewide. MSU has about 150 grant applications pending as part of the American Recovery and Reinvestment Act and expects to hear on other awards soon.


'/>"/>

Contact: Jason Cody
codyja@msu.edu
517-432-0924
Michigan State University
Source:Eurekalert

Related biology news :

1. Researchers engineer metabolic pathway in mice to prevent diet-induced obesity
2. Elevated water temperature and acidity boost growth of key sea star species: UBC researchers
3. Penn researchers discover genetic risk factor for testicular cancer
4. Understanding plants overactive immune system will help MU researchers build better crops
5. Notre Dame researchers describe new tool for evaluating managed relocations
6. UCSD researchers make first direct observations of biological particles in high-altitude ice clouds
7. 3-D kidney atlas created for researchers and physicians
8. Researchers gain genome-wide insights into patterns of the worlds human population structures
9. UMMS researchers isolate first neuroprotective gene in patients with amyotrophic lateral sclerosis
10. NOAA researchers: Blue whales re-establishing former migration patterns
11. OHSU researchers study the idling brain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
(Date:3/22/2016)... 2016 According to ... for Consumer Industry by Type (Image, Motion, Pressure, ... & IT, Entertainment, Home Appliances, & Wearable ... 2022", published by MarketsandMarkets, the market for ... USD 26.76 Billion by 2022, at a ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche ... with peritoneal or pleural mesothelioma. Their findings are the subject of a new article ... Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... pleased to announce the launch of their brand, UP4™ Probiotics, into Target stores ... 35 years, is proud to add Target to its list of well-respected retailers. ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology: